Adaptive Biotechnologies Corp (NAS:ADPT)
$ 6.13 -0.25 (-3.92%) Market Cap: 941.56 Mil Enterprise Value: 838.75 Mil PE Ratio: 0 PB Ratio: 4.20 GF Score: 81/100

Adaptive Biotechnologies Corp at William Blair Growth Stock Conference Transcript

Jun 08, 2022 / 08:20PM GMT
Release Date Price: $7.78 (+12.10%)
Brian David Weinstein
William Blair & Company L.L.C., Research Division - Partner, Group Head of Life Sciences & Healthcare Analyst

Good afternoon. My name is Brian Weinstein. I'm the Group Head of Life Sciences here at William Blair. I'm responsible for coverage of Adaptive. I also cover broadly life science tools and diagnostics.

My Compliance Officer, Mr. Michael Besenjak, who's birthday is this week, please wish him a happy birthday, he's told me to tell you that to go -- you should go to our website at williamblair.com for a complete list of disclosures or conflicts. Logistically, management presentation followed by a brief Q&A between me and the management team together about 30 minutes. Following this, we will do a breakout upstairs in the Richardson Room. That will be a fireside chat. And obviously, we would welcome your questions at that time.

With that, let's jump in today. We are fortunate to have Chad Robins, fellow Chicagoan, fellow North sider, Central Suburban League guy as well and a fellow pickleball player, we got a lot in common, the company's CEO and Co

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot